Four-component research blend containing GHK-Cu, BPC-157, TB-500 10mg and KPV, supplied as a lyophilised vial.
KLOW combines four separate research peptides: GHK-Cu, BPC-157, TB-500 and KPV. It is studied in controlled laboratory and preclinical models involving extracellular-matrix signalling, cellular migration, angiogenic responses and inflammatory pathways. The combined blend has not been clinically evaluated. For laboratory research only. Not for human or veterinary use.
